259 related articles for article (PubMed ID: 7187065)
1. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis therapy and enzyme induction in man.
Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
[TBL] [Abstract][Full Text] [Related]
3. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
Modai J; Coulaud JP; Vivien JM; Berthelot G; Bergogne-Berezin E
Nouv Presse Med; 1978 Apr; 7(15):1263-7. PubMed ID: 662655
[TBL] [Abstract][Full Text] [Related]
4. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Ahn HC; Lee YC
Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
[TBL] [Abstract][Full Text] [Related]
5. [Tisamide in the complex treatment of tuberculosis].
Onishchenko VV; Sokolova GB; Koriakin VA; Shapatava MN; Iurchenko LN
Probl Tuberk; 1990; (7):43-5. PubMed ID: 2235951
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
7. [Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
Loos U; Musch E; Schwabe HK
Pneumologie; 1990 Feb; 44 Suppl 1():488-9. PubMed ID: 2367445
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
9. Influence of rifampicin and isoniazid on the kinetics of phenytoin.
Kay L; Kampmann JP; Svendsen TL; Vergman B; Hansen JE; Skovsted L; Kristensen M
Br J Clin Pharmacol; 1985 Oct; 20(4):323-6. PubMed ID: 4074601
[TBL] [Abstract][Full Text] [Related]
10. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
11. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
[TBL] [Abstract][Full Text] [Related]
12. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
Garg SK; Dhand R; Malik SK; Kalra S; Gupta PH; Jha VK; Shukla VK; Lal R
Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):417-20. PubMed ID: 3220617
[TBL] [Abstract][Full Text] [Related]
13. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
Bouayad Z; Chevalier B; Maurin R; Bartal M
Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
[TBL] [Abstract][Full Text] [Related]
14. The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite.
Walubo A; Chan K; Woo J; Chan HS; Wong CL
Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):545-50. PubMed ID: 1956209
[TBL] [Abstract][Full Text] [Related]
15. Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians.
Perry W; Jenkins MV
Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):344-8. PubMed ID: 3733284
[TBL] [Abstract][Full Text] [Related]
16. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
El-Sayed Zaki M; Goda T
Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
[TBL] [Abstract][Full Text] [Related]
17. [Enzymatic induction during isoniazid therapy (author's transl)].
Micheletti C; Percheron F; Foglietti MJ
Pathol Biol (Paris); 1979 Oct; 27(8):479-82. PubMed ID: 392418
[TBL] [Abstract][Full Text] [Related]
18. [Condition of the liver in patients with chronic pulmonary tuberculosis receiving a combination of antibacterial drugs including rifampicin and ethambutol].
Kondrat'eva VI; Umarova MK; Arifkhanova SI
Probl Tuberk; 1977; (2):35-40. PubMed ID: 866309
[No Abstract] [Full Text] [Related]
19. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
Grönhagen-Riska C; Hellstrom PE; Fröseth B
Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistant tuberculosis in Budapest.
Fodor T; Vadász I; Lõrinczi I
Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
